Additionally, native GLP-1 attenuates infarct size after ischemia/reperfusion in in vivo and isolated perfused hearts [81], and liraglutide improves myocardial infarction (MI) outcomes in both diabetic and non-diabetic mice [83]. This evidence concerns the gene GCG and myocardial infarction.